Cerity Partners
ERAS icon

Cerity Partners’s Erasca ERAS Stock Holding History

Cerity Partners’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750K Sell
40,966
-14,794
-27% -$212K ﹤0.01% 2174
2026
Q1 		$902K Sell
55,760
-5,776
-9% -$68.3K ﹤0.01% 1919
2025
Q4 		$229K Buy
61,536
+121
+0.2% +$340 ﹤0.01% 2558
2025
Q3 		$134K Buy
61,415
+3,598
+6% +$5.72K ﹤0.01% 2583
2025
Q2 		$73.4K Buy
57,817
+22,313
+63% +$29.9K ﹤0.01% 2518
2025
Q1 		$48.6K Buy
+35,504
New +$60.9K ﹤0.01% 2402

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Cerity Partners's ERAS Position: Q2 2026 in Review

Cerity Partners reduced its Erasca (ERAS) stake by 27% in Q2 2026, selling an estimated $212K and leaving 40,966 shares worth $750K. The position accounts for ﹤0.01% of the portfolio, ranked #2174.

Cerity Partners first reported a position in ERAS in Q1 2025 and has held it in 6 quarters since. The position peaked at $902K in Q1 2026. 239 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Cerity Partners held 40,966 shares of Erasca worth $750K as of Q2 2026.
  • Cerity Partners sold 14,794 Erasca shares in Q2 2026, an estimated $212K.
  • Erasca made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2174 holding.
  • Cerity Partners first reported a position in Erasca in Q1 2025 and has held it in 6 quarters since.
  • Cerity Partners's Erasca position peaked at $902K in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.